Class IIOngoingD-0811-2026
Drug recall · September 9, 2026
Vasopressin recall
Why: CGMP Deviations
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Vasopressin, in 0.9% Sodium Chloride Injection, 20 units per 100 mL (0.2 units/mL), 100mL Single-Dose Container, Rx only, Sterile, Baxter Healthcare Corporation, Deerfield, IL, 60012 USA, NDC 0338-9640-12.
- Lots / codes
Lot # NC193672, NC193795, Exp Date: 04/30/2028; Lot # NC194198, Exp Date: 05/31/2028.
- Quantity
- N/A
- Company
- Baxter Healthcare Corporation, Deerfield, IL
- Distribution
- US Nationwide; Puerto Rico; and Chile.
- Initiated
- August 6, 2026 · Voluntary: Firm initiated
- Classified
- August 28, 2026
- Reported
- September 9, 2026
- How notified
- Letter
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Class IIOngoingSep 9, 2026Vancomycin InjectionBaxter Healthcare Corporation · D-0805-2026Class IIOngoingSep 9, 2026MYXREDLINBaxter Healthcare Corporation · D-0806-2026Class IIOngoingSep 9, 2026DaptomycinBaxter Healthcare Corporation · D-0807-2026Class IIOngoingSep 9, 2026Clindamycin Injection USP in 5% DextroseBaxter Healthcare Corporation · D-0808-2026Class IIOngoingSep 9, 2026Famotidine Injection in Sodium Chloride InjectionBaxter Healthcare Corporation · D-0809-2026Class IIOngoingSep 9, 2026Dexmedetomidine Hydrochloride in 0.9% Sodium Chloride InjectionBaxter Healthcare Corporation · D-0810-2026Class IIOngoingSep 9, 2026Pantoprazole Sodium in 0.9% Sodium Chloride InjectionBaxter Healthcare Corporation · D-0812-2026Class IIOngoingSep 9, 2026CARDENE IVBaxter Healthcare Corporation · D-0813-2026Class IIOngoingSep 9, 2026NexteroneBaxter Healthcare Corporation · D-0814-2026Class IIOngoingSep 9, 2026Clindamycin Injection USP in 5% DextroseBaxter Healthcare Corporation · D-0815-2026Class IIOngoingSep 9, 2026Clindamycin Phosphate in 0.9% Sodium Chloride InjectionBaxter Healthcare Corporation · D-0816-2026Class IIOngoingSep 9, 2026Clindamycin Injection USP in 5% DextroseBaxter Healthcare Corporation · D-0817-2026
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.